- Health A to Z
- Healthy Living
News: May 28, 2012
Older Lung Cancer Patients Less Likely to Be Treated
FRIDAY, May 4 (HealthDay News) -- A study of seniors with non-small cell lung cancer found that older patients are less likely to receive treatment than younger patients, regardless of their overall health and prognosis. Non-small cell lung cancer...
Avastin No Benefit to Older Lung Cancer Patients: Study
TUESDAY, April 17 (HealthDay News) -- Medicare patients who have advanced non-small cell lung cancer appear to get no survival benefit from adding the drug Avastin to standard chemotherapy, researchers from the Dana-Farber Cancer Institute report....
Early Study Finds Some Promise for Lung Cancer Vaccine
WEDNESDAY, April 4 (HealthDay News) -- A new therapeutic vaccine appears to lengthen the lives of patients with a certain type of lung cancer, according to results of a small phase 2 trial. The drug, belagenpumatucel-L (Lucanix), extended the live...
Hispanics Seem to Have Better Odds of Lung Cancer Survival
MONDAY, April 23 (HealthDay News) -- Hispanic people with lung cancer tend to live longer than white or black people with the disease, according to a new study. Researchers say Hispanics' increased likelihood of survival may be due to genetic fact...
Radiation After Lung Cancer Surgery Doesn't Help All: Study
MONDAY, Feb. 13 (HealthDay News) -- For older people with a certain type and stage of lung cancer, administering radiation treatment after surgery may not extend survival, according to a new study. Radiation is not without risks, and the new study...
Test Might Predict Risk of Lung Cancer's Return
THURSDAY, Jan. 26 (HealthDay News) -- A new industry-funded study suggests that a molecular test can provide insight into whether patients are at high risk of a relapse after surgical treatment for a form of lung cancer. The test, which is current...
Mixed News on Tough-to-Treat Lung Cancer
TUESDAY, Jan. 10 (HealthDay News) -- Dutch researchers report disappointing results from an early clinical trial of the drug Nexavar (sorafenib) in fighting a tough-to-treat form of lung cancer. But, in better news, an experimental drug known as g...
Targeted Drugs, Lung CT Screening Top Cancer Advances in 2011
TUESDAY, Dec. 6 (HealthDay News) -- As the war against cancer continues, a group representing U.S. oncologists has picked its "Top Five" list of advances in cancer care for 2011. Leading the list are approvals for a bevy of new, targeted drugs for...
New Treatment May Boost Survival in Advanced Lung Cancer Cases
WEDNESDAY, Nov. 9 (HealthDay News) -- For the first time, "epigenetic" therapy has shown promise in patients with solid tumors, in this case non-small cell lung cancers. Of 45 patients in a trial of this experimental treatment, two had a complete ...
Experimental Vaccine Shows Promise for Lung Cancer: Study
MONDAY, Oct. 24 (HealthDay News) -- New research suggests that physicians may be able to strengthen the power of chemotherapy in patients with the most common form of lung cancer by adding a cancer vaccine to the treatment. The combined treatment ...
Xalkori Approved for Advanced Lung Cancer
MONDAY, Aug. 29 (HealthDay News) -- Xalkori (crizotinib) and a companion diagnostic test have been approved by the U.S. Food and Drug Administration to treat advanced non-small cell lung cancer (NSCLC) with a certain genetic abnormality, the agenc...
Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study
MONDAY, Aug. 8 (HealthDay News) -- Countering conventional wisdom, researchers in France say that elderly lung cancer patients can gain significant benefit from an aggressive, double-barreled chemotherapy that's often used in younger patients. The...
Tarceva Battles Lung Cancer in Some
THURSDAY, July 21 (HealthDay News) -- New research finds that the targeted cancer drug Tarceva nearly triples the amount of time lung cancer patients survive without a recurrence and has fewer side effects than standard chemotherapy. The authors o...
Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
TUESDAY, July 5 (HealthDay News) -- A drug designed to treat certain patients with non-small cell lung cancer boosts survival time without progression of cancer by several months, according to a new study. The findings reveal that the drug, known ...
Taking Chemo Drug Continuously Delayed Lung Cancer's Return
SUNDAY, June 5 (HealthDay News) -- While most patients with advanced lung cancer only take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of the deadly di...
Lung Cancer Evolves With Treatment, Study Finds
WEDNESDAY, March 23 (HealthDay News) -- A new study helps explain how some lung cancers become resistant to targeted drug therapy. Researchers at the Massachusetts General Hospital Cancer Center analyzed tumor samples from 37 patients with non-sma...
Rash Due to Lung Cancer Drug May Be Linked to Better Survival
MONDAY, Dec. 20 (HealthDay News) -- Lung cancer patients who develop a rash after treatment with the drug cetuximab (Erbitux) have better outcomes, according to a new study. German researchers compared hundreds of patients with non-small cell lung...
Gene Research Sheds Light on Lung Cancer Survival Time
WEDNESDAY, Dec. 15 (HealthDay News) -- Genes that predict length of survival and help guide treatment for patients with non-small cell lung cancer have been identified by U.S. researchers. The investigators took samples of lung tumors and nearby h...
Race Doesn't Seem to Predict Lung Cancer Survival in Blacks
SATURDAY, Oct. 2 (HealthDay News) -- Race does not appear to play a role in how long a black patient or a white patient with lung cancer will ultimately survive the disease, researchers report. "In simple terms, if 100 patients who are [white] and...
Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung cancers, researchers report. Previously it had bee...
Researchers Report Treatment Headway Against Lung Cancer
SATURDAY, June 5 (HealthDay News) -- Researchers report they prolonged survival for some patients with advanced non-small cell lung cancer, for whom the median survival is currently only about six months. One study discovered that an experimental ...
Don't Count on Selenium to Prevent Lung Cancer Recurrence
SATURDAY, June 5 (HealthDay News) -- Taking the popular mineral supplement selenium doesn't reduce the likelihood of lung cancer recurrence, a new study reveals. Lead author Dr. Daniel D. Karp, a professor in the department of thoracic/head and ne...
Single Lung Tumor Contains 50,000 Mutated Genes
WEDNESDAY, May 26 (HealthDay News) -- Malignant lung tumors may contain not one, not two, but potentially tens of thousands of genetic mutations which, together, contribute to the development of the cancer. A sample from a lung tumor from a heavy ...
Post-Chemo Treatment May Boost Lung Cancer Survival
THURSDAY, May 20 (HealthDay News) -- Among people with non-small-cell lung cancer, treatment with the drug erlotinib (Tarceva) after chemotherapy appears to slightly boost survival rates, a new study suggests. Non-small-cell lung cancer makes up a...
Matching Tumor Types to Drugs Boosts Lung Cancer Outcomes
SUNDAY, April 18 (HealthDay News) -- The number one cancer killer, lung cancer, may be more susceptible to treatment when doctors match up targeted drugs to tumors with key genetic traits, a new study finds. The study -- the first of its kind -- f...
Chemo May Boost Survival After Lung Cancer Surgery
WEDNESDAY, March 24 (HealthDay News) -- Chemotherapy improves survival for patients with operable non-small cell lung cancer, say researchers who reviewed nearly 50 studies. The first meta-analysis of 34 studies involving almost 8,500 patients (an...
Radiation May Help Those With Inoperable Lung Tumors
TUESDAY, March 16 (HealthDay News) -- A carefully targeted and powerful regimen of radiation therapy kept early-stage lung tumors stable in patients who had inoperable cancers. Almost 56 percent of patients who underwent the therapy, called stereo...
Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
TUESDAY, Feb. 9 (HealthDay News) -- U.S. scientists have discovered there are genetic profiles that play a part in prognosis with non-small cell lung cancers, and those profiles differ depending on the age and gender of the patient. The researcher...
Strides Made in Lung Cancer Treatment
WEDNESDAY, Jan. 13 (HealthDay News) -- Advances in genetics and biomarker identification and testing are finally bearing fruit in the battle against lung cancer, a new set of studies suggests. Until now, lung cancer has lagged behind other maligna...
New Drug May Offer Hope to Some With Lung Cancer
SATURDAY, Sept. 19 (HealthDay News) -- Maintenance therapy with the drug pemetrexed improves the survival of people with non-small-cell lung cancer whose disease has not progressed after chemotherapy, a new study has found. Nearly 90 percent of al...
Hormone Therapy May Make Lung Cancer More Likely
SATURDAY, Sept. 19 (HealthDay News) -- Taking a combination form of hormone replacement therapy, which includes both estrogen and progestin, increases a woman's risk for dying from lung cancer, a new study has found. The finding stems from an anal...
Gene Mutation Improves Response to Lung Cancer Drug
WEDNESDAY, Aug. 19 (HealthDay News) -- People with lung cancer who are screened for a genetic mutation and then given a drug called Tarceva, which is believed to work well with that mutation, live longer than those without the mutation who take th...
Radiation Plus Chemo a Good Option in Lung Cancer
MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found. Stage 3A is declared when surgery cannot cure the disease because i...
Alimta Approved as Maintenance Therapy for Advanced Lung Cancer
MONDAY, July 6 (HealthDay News) -- The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday. The drug,...
Nicotine Receptors Could Be Lung Cancer Treatment Target
MONDAY, June 15 (HealthDay News) -- In a study of mice with lung cancer, a treatment that targeted nicotine receptors more than doubled the animals' survival time, Italian researchers say. Nicotine plays a dual role in lung cancer. Changes in gene...
Coming Soon: Lung-Cancer Spray?
MONDAY, June 15 (HealthDay News) -- Scientists may someday be able to fight lung cancer using gene therapy delivered by an inhalable spray. In a new study, mice with lung cancer that were treated with a vaporized viral vector twice a week for four...
Drug Trials Show Modest Gains Against Lung Cancer
SATURDAY, May 30 (HealthDay News) -- Certain drugs offer incremental yet significant improvements in pushing back advanced lung cancer. That's the conclusion of studies presented Saturday at the annual meeting of the American Society of Clinical O...
HRT Ups Death Risk for Women With Lung Cancer
SATURDAY, May 30 (HealthDay News) -- The current use of combined hormone replacement therapy (HRT) is associated with a higher risk of dying for women diagnosed with non-small cell lung cancer, a new study shows. The risk was highest in current sm...
Drug Combo Proves Powerful Against Lung Cancer
SATURDAY, May 30 (HealthDay News) -- A two-drug combination treatment proved successful in safely slowing advanced non-small cell lung cancer in a recent clinical trial. In the study, a phase 3 trial involving 768 people with the disease, those wh...
Blacks Less Likely to Get Optimal Lung Cancer Treatment
MONDAY, April 13 (HealthDay News) -- Black patients with lung cancer are less likely than white patients to receive recommended chemotherapy and surgery, a new study finds. Disparities in lung cancer treatments were as large in 2002 as they were b...
Advertisement
